Cerus (CERS) Misses Q4 EPS by 2c
Get Alerts CERS Hot Sheet
Price: $2.36 +3.51%
Financial Fact:
Foreign exchange gain (loss): -61K
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Foreign exchange gain (loss): -61K
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Cerus (NASDAQ: CERS) reported Q4 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $44.03 million versus the consensus estimate of $49.16 million.
For earnings history and earnings-related data on Cerus (CERS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerus (CERS) Tops Q3 EPS by 2c, offers product revenue guidance
- Neurocrine Biosciences (NBIX) Tops Q3 EPS by 138c
- Hinge Health, Inc. (HNGE) Tops Q3 EPS by 6c, raises Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share